Araceli Biosciences Inc. — Form D/A

Araceli Biosciences Inc. of TIGARD, OR, a company, filed a Form D amendment with the SEC on 2025-12-09. The offering totals $14.1M, of which $12.2M was reported sold. Industry: Other Technology.

Offering

Issuer

Officers, directors & promoters (20)

NameRoleLocation
Matt BeaudetDirectorTigard, OR
William CortelyouDirectorTigard, OR
J. William FreytagDirectorTigard, OR
Kevin GabeleinDirectorTigard, OR
Kirk MalloyDirectorTigard, OR
Sean O'NeillDirectorWALTHAM, MA
Samraat RahaDirectorTigard, OR
Bruce RhineDirectorTigard, OR
Matt BeaudetExecutive OfficerTigard, OR
Shawn MacDonaldExecutive OfficerTigard, OR
Kirk William MalloyDirectorTigard, OR
J. William FreytagDirectorTigard, OR
Shawn William MacDonaldExecutive OfficerTigard, OR
Sean William O'NeillDirectorTigard, OR
Kevin William GabeleinDirectorTigard, OR
Jeff William HarrisExecutive OfficerTigard, OR
William B CortelyouDirectorTigard, OR
Bruce William RhineDirectorTigard, OR
Scott William IglExecutive OfficerTigard, OR
Samraat William RahaDirectorTigard, OR

Other filings by this issuer (2)

FiledFormOfferingSold
2025-01-15D$8.0M$2.5M
2023-04-26D$4.0M$2.2M

More